Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gibraltar Industries is a U.S.-based publicly traded manufacturer and provider of products and services for the residential, agtech, and infrastructure markets. The company operates across building products, controlled-environment agriculture, and engineered infrastructure solutions, with brands and businesses that serve home improvement, food production, and civil construction end markets. Its agtech operations, including greenhouse and growing solutions, are focused on controlled environment agriculture rather than human healthcare or biotechnology. Gibraltar has also been reshaping its portfolio, including the February 2026 acquisition of OmniMax International and the strategic divestiture of parts of its renewables business. Overall, Gibraltar is an industrial and agtech company, not a life sciences, biotech, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gibraltar Industries.